9月15日15:49,同源康医药-B(02410)大幅上涨5.05%,该股报15.380港元,最高报15.380港元,最低报14.250港元,成交量479.71万股,成交额7032.25万港元。消息面上,近日,同源康医药自主研发的创新药艾多替尼片(TY-9591)针对EGFR突变晚期非小细胞肺癌(NSCLC)的关键注册Ⅱ期临床试验(NCT05948813)结果获选WCLC 2025大会Mini ...
Source Link9月15日15:49,同源康医药-B(02410)大幅上涨5.05%,该股报15.380港元,最高报15.380港元,最低报14.250港元,成交量479.71万股,成交额7032.25万港元。消息面上,近日,同源康医药自主研发的创新药艾多替尼片(TY-9591)针对EGFR突变晚期非小细胞肺癌(NSCLC)的关键注册Ⅱ期临床试验(NCT05948813)结果获选WCLC 2025大会Mini ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.